Neonatal seizures

Current Treatment Options in Neurology

Volumn 11, Issue 6, 2009, Pages 405-413

  Glass, Hannah C ^a   Sullivan, Joseph E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; FOLINIC ACID; FOSPHENYTOIN SODIUM; LIDOCAINE; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PYRIDOXINE; RETIGABINE; TOPIRAMATE;

ALGORITHM; ANAMNESIS; ARTIFACT; AUTOMATION; BLOOD DYSCRASIA; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; CRYING; DIFFUSION WEIGHTED IMAGING; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SOLUBILITY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FOLIC ACID DEFICIENCY; HEART ARRHYTHMIA; HEMORRHAGIC GASTRITIS; HUMAN; HYPOTENSION; INJECTION SITE REACTION; LABORATORY TEST; LIVER TOXICITY; LONG TERM CARE; LOW DRUG DOSE; METABOLIC DISORDER; MUSCLE HYPOTONIA; MYOCLONUS; NEUROIMAGING; NEUROPATHY; NEUROPROTECTION; NEWBORN DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OFF LABEL DRUG USE; PATIENT MONITORING; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; REPEATED DRUG DOSE; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; RESTLESSNESS; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SEDATION; SEIZURE; SHORT COURSE THERAPY; SIDE EFFECT; SKIN DISEASE; SUBARACHNOID HEMORRHAGE; TREATMENT WITHDRAWAL; VERY LOW BIRTH WEIGHT;

EID: 70350179952     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-009-0045-1     Document Type: Review

References (48)

1. Glass HC, Pham TN, Danielsen B, et al.: Antenatal and intrapartum risk factors for seizures in term newborns: A population-based study, California 1998-2002. J Pediatr 2009, 154:24-28.e1.
2. Lanska MJ, Lanska DJ, Baumann RJ, et al.: A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology 1995, 45:724-732.
3. Saliba RM, Annegers JF, Waller DK, et al.: Incidence of neonatal seizures in Harris County, Texas 1992-1994. Am J Epidemiol 1999, 150:763-769.
4. Annegers JF, Hauser WA, Lee JR, et al.: Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995, 36:327-333.
5. Jensen FE: Developmental factors regulating susceptibility to perinatal brain injury and seizures. Curr Opin Pediatr 2006, 18:628-633.
6. Tekgul H, Gauvreau K, Soul J, et al.: The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics 2006, 117:1270-1280.
7. Ronen GM, Buckley D, Penney S, et al.: Long-term prognosis in children with neonatal seizures: A population-based study. Neurology 2007, 69:1816-1822.
8. Volpe JJ: Neonatal seizures. In Neonatal Neurology. Edited by Volpe JJ. Philadelphia: WB Saunders; 2008:203-244.
9. Soldovieri MV, Miceli F, Bellini G, et al.: Correlating the clinical and genetic features of benign familial neonatal seizures (BFNS) with the functional consequences of underlying mutations. Channels (Austin) 2007, 1:228-233.
10. Ohtahara S, YWmatogi Y: Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res 2006, 70(Suppl 1):S58-S67.
11. Djukic A, Lado FA, Shinnar S, et al.: Are early myoclonic encephalopathy (EME) and the Ohtahara syndrome (EIEE) independent of each other? Epilepsy Res 2006, 70(Suppl 1):S68-S76.
12. Silverstein FS, Jensen FE: Neonatal seizures. Ann Neurol 2007, 62:112-120.
13. Jiang M, Lee CL, Smith KL, et al.: Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy. J Neurosci 1998, 18:8356-8368.
14. McCabe BK, Silveira DC, Cilio MR, et al.: Reduced neurogenesis after neonatal seizures. J Neurosci 2001, 21:2094-2103.
15. Montgomery EM, Bardgett ME, Lall B, et al.: Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats. Brain Res Dev Brain Res 1999, 112:107-116.
16. Lynch M, Sayin U, Bownds J, et al.: Long-term consequences of early postnatal seizures on hippocampal learning and plasticity. Eur J Neurosci 2000, 12:2252-2264.
17. Miller SP, Weiss J, Barnwell A, et al.: Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 2002, 58:542-548.
18. Glass HC, Glidden D, Jeremy RJ, et al.: Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediatr 2009, 155:318-323.
19. Silverstein FS, Jensen FE, Inder T, et al.: Improving the treatment of neonatal seizures: National Institute of Neurological Disorders and Stroke workshop report. J Pediatr 2008, 153:12-15.
20. Bonifacio SL, Miller SP: Neonatal seizures and brain imaging. J Pediatr Neurol 2009, 7:61-67.
21. Mader I, Schoning M, Klose U, et al.: Neonatal cerebral infarction diagnosed by diffusion-weighted MRI: Pseudonormalization occurs early. Stroke 2002, 33:1142-1145.
22. Kuker W, Mohrle S, Mader I, et al.: MRI for the management of neonatal cerebral infarctions: Importance of timing. Childs Nerv Syst 2004, 20:742-748.
23. Barkovich AJ, Miller SP, Bartha A, et al.: MR imaging, MR spectroscopy, and diffusion tensor imaging of sequential studies in neonates with encephalopathy. AJNR Am J Neuroradiol 2006, 27:533-547.
24. Weiner SP, Painter MJ, Geva D, et al.: Neonatal sei zures: electroclinical dissociation. Pediatr Neurol 1991, 7:363-368.
25. Pisani F, Cerminara C, Fusco C, et al.: Neonatal status epilepticus vs recurrent neonatal seizures: Clinical findings and outcome. Neurology 2007, 69:2177-2185.
26. Shellhaas RA, Soaita AI, Clancy RR: Sensitivity of amplitude-integrated electroencephalography for neonatal seizure detection. Pediatrics 2007, 120:770-777.
27. Clancy RR: Prolonged electroencephalogram monitoring for seizures and their treatment. Clin Perinatol 2006, 33:649-665.
28. Bartha AI, ShMn J, Katz KH, et al.: Neonatal seizures: multi center variability in current treatment practices. Pediatr Neurol 2007, 37:85-90.
29. Wheless JW, Clarke DF, Arzimanoglou A, et al.: Treatment of pediatric epilepsy: European expert opinion 2007. Epileptic Disord 2007, 9:353-412.
30. Bassan H, BenDal Y, Shany E, et al.: Neonatal seizures: dilemmas in workup and management. Pediatr Neurol 2008, 38:415-421.
31. Painter MJ, Scher MS, Stein AD, et al.: Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999, 341:485-489.
32. Malingre MM, Van Rooij LG, Rademaker CM, et al.: Development of an optimal lidocaine infusion strategy for neonatal seizures. Eur J Pediatr 2006, 165:598-604.
33. Bittigau P, Sifringer M, Genz K, et al.: Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 2002, 99:15089-15094.
34. Hellstrom-Westas L, Blennow G, Lindroth M, et al.: Low risk of seizure recurrence after early withdrawal of antiepileptic treatment in the neonatal period. Arch Dis Child Fetal Neonatal Ed 1995, 72:F97-F101.
35. Levene M: The clinical conundrum of neonatal seizures. Arch Dis Child Fetal Neonatal Ed 2002, 86:F75-F77.
36. Guillet R, Kwon J: Seizure recurrence and developmental disabilities after neonatal seizures: Outcomes are unrelated to use of phenobarbital prophylaxis. J Child Neurol 2007, 22:389-395.
37. Castro Conde JR, Hernandez Borges AA, Domenech Martinez E, et al.: Midazolam in neonatal seizures with no response to phenobarbital. Neurology 2005, 64:876-879.
38. Silverstein FS, Ferriero DM: Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol 2008, 39:77-79.
39. Hmaimess G, Kadhim H, Nassogne MC, et al.: Levetiracetam in a neonate with malignant migrating partial seizures. Pediatr Neurol 2006, 34:55-59.
40. Shoemaker MT, Rotenberg JS: Levetiracetam for the treatment of neonatal seizures. J Child Neurol 2007, 22:95-98.
41. Liu Y, Barks JD, Xu G, et al.: Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 2004, 35:1460-1465.
42. Dzhala VI, Brumback AC, Staley KJ: Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol 2008, 63:222-235.
43. Kahle KT, Barnett SM, Sassower KC, et al.: Decreased seizure activity in a human neonate treated with bumetanide, an inhibitor of the Na(+)-K(+)-2Cl(-) cotransporter NKCC1. J Child Neurol 2009, 24:572-576.
44. Tatulian L, Delmas P, Abogadie FC, et al.: Activation of expressed KCNQ potassium currents in native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J Neurosci 2001, 21:5535-5545.
45. Castaldo P, del Giudice EM, Coppola G: Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels. J Neurosci 2002, 22:RC199.
46. Rao YH, Lapides DA, Keating JG, et al.: A KCNQ channel opener for experimental neonatal seizures and status epilepticus. Ann Neurol 2009, 65:326-336.
47. Abend NS, Dlugos D, Herman S: Neonatal seizure detection using multichannel display of envelope trend. Epilepsia 2008, 49:349-352.
48. Faul S, Boylan G, Connolly S, et al.: An evaluation of automated neonatal seizure detection methods. Clin Neurophysiol 2005, 116:1533-1541.